Anthropic AI for Science event livestreams today as the company pitches Claude to pharma and biotech leaders. The session ...

Over the past several years, we have seen accelerating technological change. Machine learning is accelerating drug discovery, ...

Many new gene therapy treatments aren’t as profitable as predicted. But the reasons why don’t quite fit Goldman Sachs’ warning ...

Adds potential first-in-class,N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis ...

Ligand Pharma (LGND) stock jumped in the final week of June, but the proximate cause was the pricing of $625M of convertible ...

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, ...

By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than eight million deaths ...

Brandon Capital, Australasia’s leading life sciences venture capital firm, today announces the successful exit of its portfolio company Myricx Bio following its agreement to be acquired by Novartis.

Equity Insider News Commentary, The scramble to build a critical-minerals supply chain outside China has become one of the ...

USA News Group, There is a growing consensus in artificial intelligence that the models themselves are becoming interchangeable, and that ...

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian ...